Nicholas Grund - Insider Trading & Ownership

Entity
Individual
Location
C/O Amag Pharmaceuticals, Inc., Waltham, MA
Summary
The estimated net worth of Nicholas Grund is at least $510K dollars as of February 2, 2024. Nicholas Grund is the Chief Commercial Officer of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $510K.
All Insider Reports
All Insider Reports

Ownership of Nicholas Grund

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AKBA Akebia Therapeutics, Inc. Chief Commercial Officer $510K Jan 31, 2024

Insider Transactions Reported by Nicholas Grund:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.